Dual TLR7/8 Antagonists (Genomics Institute of the Novartis Research Foundation)

N/A

Report date: 2025/01/26 17:33:03
NME

Base Information

Drug NameDual TLR7/8 Antagonists (Genomics Institute of the Novartis Research Foundation)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 8 antagonists
TargetsToll like receptor 8Toll like receptor 7
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenomics Institute of the Novartis Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesGenomics Institute of the Novartis Research Foundation
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A